Health policy

MouthWatch 2023 Tellie Award Winners Demonstrate Continued Commitment to Innovation for Improved Oral Health

Retrieved on: 
Wednesday, December 20, 2023
Biotechnology, Medical Supplies, General Health, Health, Medical Devices, Health Technology, Dental, Other Health, X-ray, Dentistry, Documentation, DDS, Multimedia, School, Research, Student, HPI, KCMO, Health policy, KCKS, Telly, American Dental Association, Middlesex College, Oral hygiene, Patient, Organization, MDU, RDH, Tooth

MouthWatch, LLC, an industry leader in teledentistry solutions and digital imaging devices, recently announced the winners of the 6th Annual Teledentistry Innovation Awards, “The Tellies”.

Key Points: 
  • MouthWatch, LLC, an industry leader in teledentistry solutions and digital imaging devices, recently announced the winners of the 6th Annual Teledentistry Innovation Awards, “The Tellies”.
  • Missing from the photo: Marko Vujicic, Chief Economist & Vice President, American Dental Association (ADA) Health Policy Institute.
  • The Tellies celebrate individuals, organizations, and programs that demonstrate a passion for continuous innovation, improved access to care, and better oral health through the use of teledentistry and virtual dental care applications.
  • To learn more about the Teledentistry Innovation Awards and this year’s winners, visit teledentistryinnovationawards.com .

African Insight Informs AHF’s Pandemic Governance and Funding Recommendations

Retrieved on: 
Tuesday, December 19, 2023
University, Biotechnology, Education, AIDS, Other Health, Health, Healthcare Reform, Public Policy, Other Policy Issues, Infectious Diseases, Government, Partnership, Pandemic, Agreement, AHF, Developing country, Health policy, Tuberculosis, Negotiation, PPPR, Public, World Health Organization, Global health, Pharmaceutical industry

In a collaborative effort to reshape global health policy discourse, the AHF Global Public Health Institute , in partnership with the University of Miami Public Health Policy Lab and AHF Africa Bureau, has released a critical report titled " African Insights: Recommendations for Global Pandemic Governance and Funding 2023 ."

Key Points: 
  • In a collaborative effort to reshape global health policy discourse, the AHF Global Public Health Institute , in partnership with the University of Miami Public Health Policy Lab and AHF Africa Bureau, has released a critical report titled " African Insights: Recommendations for Global Pandemic Governance and Funding 2023 ."
  • The report is comprised of eleven recommendations derived from a set of consultations with key non-governmental African global public health experts and thought leaders on critical issues of global health.
  • Notably, this report offers recommendations on the governance of global health financing, the WHO Pandemic Agreement, and regional strategies for pandemic prevention, preparedness, and response (PPPR).
  • It also highlights the importance of further integrating African voices in the global health discourse, ensuring that the region's specific needs and insights are adequately addressed in global pandemic deliberations.

Government of Canada announces appointments to the Canadian Institutes of Health Research Governing Council

Retrieved on: 
Thursday, December 21, 2023
Drug, Social services, Economics, Research, Homelessness, BPP, Public, Health policy, Education, University, Knowledge, CIHR, Democracy, Assistant director, Community engagement, Personal ordinariate, Patient, Teaching, Parliament, Nursing

In this capacity, Ms. Descoteaux manages the University's network of patient partners involved in research, education and health care.

Key Points: 
  • In this capacity, Ms. Descoteaux manages the University's network of patient partners involved in research, education and health care.
  • Michal Juhas is a digital health expert and independent consultant and sub-contractor in the fields of health policy, economics, and outcomes research.
  • "I am very pleased to announce the four appointments to the Canadian Institutes of Health Research (CIHR) Governing Council.
  • CIHR is part of the Health Portfolio, which supports the Minister of Health in maintaining and improving the health of Canadians.

Arbital Health Announces Esteemed Leadership Team and Advisory Board Accelerating Shift to Value-Based Care

Retrieved on: 
Tuesday, December 19, 2023
Marketing, Senior advisor, Thomson Scientific, Software, FDA, Cardinal Health, Health, Health policy, SVP, Business, Security, HST, GV, Veterans' affairs, History, Former, MD, Software as a service, GV (company), Harvard Medical School, Mount Sinai Beth Israel, National Cancer Institute, Strategy, Dropbox, Woman, Auren Hoffman, Business operations, Interim, Management

SAN FRANCISCO, Dec. 19, 2023 /PRNewswire/ -- Arbital Health, a technology startup focused on accelerating the healthcare industry's transition to value-based care, today announced its leadership team and advisors. Arbital Health announced its launch in November 2023 to solve the problem of misaligned incentives in healthcare. By creating a neutral, 3rd party utility that enables all market participants to better design, measure, and adjudicate value-based care contracts, the company will accelerate the $1 trillion shift to value-based care in the US healthcare system.

Key Points: 
  • Arbital Health announced its launch in November 2023 to solve the problem of misaligned incentives in healthcare.
  • Arbital today announced its leadership team made up of experienced healthcare and technology leaders.
  • To support the management team in its mission to solve incentive misalignment in healthcare, Arbital Health has also assembled an exemplary Senior Advisory Board.
  • "A key first step in building Arbital Health was assembling an all-star management team and advisory board," said Travis May, CEO of Shaper Capital and Chairman of Arbital Health.

Medicare Advantage vs. Original Medicare: Which is best for you?

Retrieved on: 
Wednesday, November 15, 2023
Medicare Advantage, Medicaid, Research, Health policy, Medicare Part D, FAQ, KFF, Part, Medicare (United States), Prescription, Travel, Kool-Aid, Plasma protein binding, Medicare, Medigap, Government, Health insurance

Minneapolis, MN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- With Medicare open enrollment underway, it’s helpful for consumers to understand the difference between Original Medicare and Medicare Advantage.

Key Points: 
  • Minneapolis, MN, Nov. 15, 2023 (GLOBE NEWSWIRE) -- With Medicare open enrollment underway, it’s helpful for consumers to understand the difference between Original Medicare and Medicare Advantage.
  • During the open enrollment period, millions of Medicare enrollees can :
    Switch from Original Medicare to Medicare Advantage, or vice versa.
  • Here are a few things to consider when deciding between Original Medicare versus Medicare Advantage, or pairing Original Medicare with a Medigap or Part D plan.
  • Prescription drug costs: Most Medicare Advantage plans include Medicare Part D drug coverage, but if you’re considering a Medicare Advantage plan, it’s a good idea to confirm and make sure.

The CHOICE Institute at the University of Washington Partners With Komodo Health To Drive Critical Health Economic and Outcomes Research

Retrieved on: 
Monday, December 11, 2023
Diabetes, Health Technology, Data Management, Technology, University, Education, General Health, Professional Services, Mental Health, Infectious Diseases, Hospitals, Venture Capital, Artificial Intelligence, Software, Data Analytics, Health, Komodo, Sentinel, Drug development, Hepatitis C, Research, The, Health policy, Entrepreneurship, Sickle cell disease, Pain management, Mortality, Patient, Dementia, Cognition, Ageing, Cystic fibrosis, Doctor of Philosophy, CHOICE, Nursing, Pharmaceutical industry, Pharmacy, Economics, Policy

The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy is joining forces with Komodo Health as its data and technology partner to drive comparative outcomes and cost-effectiveness research and analytics.

Key Points: 
  • The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy is joining forces with Komodo Health as its data and technology partner to drive comparative outcomes and cost-effectiveness research and analytics.
  • The CHOICE Institute envisions using Komodo’s technology to unlock high-quality insights into healthcare utilization, costs, and outcomes in the United States, working toward its vision of generating knowledge to improve individual and population health.
  • Komodo Health is the technology partner of choice for academic researchers of health economics and outcomes research (HEOR) and expediting the production of critical research-grade evidence using the most comprehensive and representative data available.
  • Academic institutions continue to be the bedrock of healthcare research, driving innovative HEOR that impacts drug development, market access, and, ultimately, patient outcomes.

Thermo Fisher Scientific and Project HOPE Partner to Advance Health Equity Among HIV Positive Youth in Sub-Saharan Africa

Retrieved on: 
Friday, December 1, 2023
Research, Philanthropy, AIDS, Health, General Health, Other Philanthropy, Other Science, Science, Oncology, Invention, Global health, Health equity, Pfizer, Thermo Fisher Scientific, Health policy, HIV/AIDS, UNAIDS, HOPE, Disease, Project, Government, Patient, Mindful Scientific Inc., Infection, FDA, Corporate social responsibility, Drug resistance, HIV, Person, Cancer, Partnership, Quality of life, Life, Vaccine, Pharmaceutical industry, Central Africa

The partnership greatly advances Project HOPE’s efforts in Northwestern Nigeria by expanding access to critical community HIV testing services.

Key Points: 
  • The partnership greatly advances Project HOPE’s efforts in Northwestern Nigeria by expanding access to critical community HIV testing services.
  • Additionally, Thermo Fisher will engage its employees in volunteer opportunities to augment the services delivered by Project HOPE.
  • “Project HOPE is delighted to collaborate with Thermo Fisher Scientific on this transformative journey to improve the lives of adolescents and young persons in Northwestern Nigeria,” said Dr. Uche RalphOpara, deputy chief health officer, Project HOPE.
  • To learn more about Thermo Fisher’s global commitment to health equity, explore the company’s Corporate Social Responsibility Report .

Mercer Survey Finds Health Benefit Costs Up 5.2% in 2023 Due to Inflation and Higher Spending on Prescription Drugs

Retrieved on: 
Friday, November 17, 2023
Professional Services, Insurance, Finance, Obesity, PPO, Risk, NYSE, Marsh McLennan, FDA, Pharmacy, Diabetes, Patient, Head, C-peptide, MMC, Health policy, Health insurance, Pharmaceutical industry, Medical device

They also reported a higher average per-employee cost for health insurance – $16,464 compared to $15,640 among larger employers with 500 or more employees.

Key Points: 
  • They also reported a higher average per-employee cost for health insurance – $16,464 compared to $15,640 among larger employers with 500 or more employees.
  • Because healthcare providers typically have multi-year contracts with health plans, employers did not feel the full brunt of inflation last year.
  • “Rather, inflation-driven cost increases are phasing in as contracts are renewed,” says Sunit Patel, Chief Health Actuary, Mercer.
  • Despite rising health plan costs, large employers largely avoided shifting additional costs to employees through higher deductibles, copays, or out-of-pocket maximums in 2023.

CUNY SPH partners with UNFPA on campaign to end gender-based violence

Retrieved on: 
Wednesday, December 13, 2023
United Nations Population Fund, Woman, Health equity, Research, Organization, UNFPA, International, Traction, History, Human Rights Day, Graduate Center, CUNY, Partnership, Public health, CWGL, Education, Public, CUNY, Health policy, SRJ, Nursing, Violence

It gained traction in more than 187 countries, with participation from over 6,000 organizations and a reach of over 300 million.

Key Points: 
  • It gained traction in more than 187 countries, with participation from over 6,000 organizations and a reach of over 300 million.
  • The campaign will now be housed at CUNY SPH, ensuring that the important work of CWGL will continue going forward.
  • "Now more than ever, protecting the right to reproductive autonomy is crucial," says CUNY SPH Dean Ayman El-Mohandes.
  • "We're proud to add this partnership to the SRJ work CUNY SPH is engaged in, especially at this dire point in history when these rights are being steadily eroded on many fronts."

World Innovation Summit for Health Announces Dates for 2024 Event and Strategic Partnership with WHO

Retrieved on: 
Wednesday, December 6, 2023
Ministry, World Health Organization, Global health, Education, Health policy, Qatar Foundation, Community development, WHO, Ethics, QF, Multimedia, Health, Partnership, Public health, Mental health, Palliative care, News, Tuberculosis, Medical device, Science, WISH

DOHA, Qatar, Dec. 6, 2023 /PRNewswire/ -- The World Innovation Summit for Health (WISH), an initiative of Qatar Foundation for Education, Science and Community Development (QF), announced the WISH 2024 summit will take place in Doha on November 13 and 14, 2024.

Key Points: 
  • DOHA, Qatar, Dec. 6, 2023 /PRNewswire/ -- The World Innovation Summit for Health (WISH), an initiative of Qatar Foundation for Education, Science and Community Development (QF), announced the WISH 2024 summit will take place in Doha on November 13 and 14, 2024.
  • WISH 2024 will be the seventh edition of WISH – an event now firmly established as a vital feature on the global health calendar.
  • Central to the partnership will be three WHO-led collaborative research projects, generating evidence-based reports for in-depth discussion at event.
  • Additionally, local and international partners will work with WISH to develop reports for the summit on a range of issues in areas such as health systems, ethics, physical health, and mental health.